Next Generation Implants (NGI) Market Trends- High Focus on Developing Cost-Effective NGI

Increasing incidence of orthopedic diseases and age-related disorders, growing demand for smaller and compact implants, and rising geriatric population are some key factors expected to drive global market growth

According to Emergen Research, the global next generation implants market size was USD 3.43 billion in 2020 and is expected to reach USD 4.45 billion in 2028 and register a steady CAGR of 3.2% during the forecast period, 2021-2028.

Market Dynamics:

Next Generation Implants (NGI) are medical devices that are designed for replacing missing body parts or providing support for new tissue generation and bone structure. These implants help patients recover faster and continue their routine activities. Rapid advancements in implant technology have led to the introduction of more advanced and simplified next-generation devices and products. Many leading companies are heavily investing and are focused on developing next-generation implants such as pacemakers, implantable defibrillators, blood pressure sensors, neurostimulators, and renal implants.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

Factors such as rapid advancements in medical implants, increasing adoption of Artificial Intelligence (AI) and Machine Learning (ML) for improving overall performance and increasing investments in developing advanced, more efficient, and affordable next generation implants are expected to drive global market revenue growth during the forecast period. In addition, growing awareness about the benefits of NGI, rising healthcare expenditure, and increasing disposable income are other key factors expected to drive global market growth going ahead.

However, high cost of next generation implants, limited access to advanced technologies due to lack of funds and budget constraints, and low awareness about advanced medical implants in many developing economies are expected to hamper overall revenue growth to a certain extent during the forecast period.

COVID-19 Impact Analysis 

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Cardiovascular Implants Segment To Register Rapid Revenue Growth: 

The cardiovascular implants segment is expected to register rapid revenue growth during the forecast period owing to increasing prevalence of cardiovascular diseases across the globe, rapid adoption of cardiac devices such as pacemakers, cardiac valves, implantable defibrillators, and stents, and ongoing research on developing more efficient and compact cardiovascular implants. 

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

Hospitals Segment to Account for Significantly Larger Revenue Share:

The hospitals segment is expected to account for a significantly larger revenue share over the forecast period. This can be attributed to factors such as increasing prevalence of orthopedic diseases, rising patient admission, improving healthcare infrastructure, and growing demand for advanced implants.  

North America to Lead In Terms of Revenue Share:

North America is expected to account for largest revenue share during the forecast period owing to increasing prevalence of chronic and age-related diseases, rising geriatric population, and rapid advancements in medical implants. In addition, increasing R&D activities, growing awareness about the benefits of next generation implants, presence of leading manufacturing companies, rising healthcare spending, and increasing funds by public and private organizations to develop more advanced implants are expected to drive North America market growth during the forecast period.   

Major Companies in the Market Include:

  • Abbott Laboratories
  • Smith & Nephew plc
  • Johnson & Johnson
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Medtronic Public Limited Company
  • Wright Medical Group N.V
  • Stryker Corporation
  • Globus Medical Inc.
  • Zimmer Biomet Holdings Inc.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@

Segments Covered in Next Generation Implants (NGI) report

Report Details


The market size in 2020

USD 3.43 Billion

CAGR (2021---2028)


The revenue forecast in 2028

USD 4.45 Billion

Base year for estimation


Forecast period


Quantitative units

Revenue in USD Billion, and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Application, material, end-use, and regions.

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa.

Country scope

U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; India; Japan; South Korea; Brazil; Saudi Arabia; South Africa; Turkey.

Key companies profiled

Abbott Laboratories, Smith & Nephew plc, Johnson & Johnson, Boston Scientific Corporation, C.R. Bard, Inc., Medtronic Public Limited Company, Wright Medical Group N.V, Stryker Corporation, Globus Medical Inc, DENTSPLY SIRONA Inc, and Zimmer Biomet Holdings Inc.

Customization scope

10 hours of free customization and expert consultation


For the purpose of this report, Emergen Research has segmented the next generation implants (NGI) market based on application, material, end-use, and region as follows:

Application Outlook (Revenue: USD Billion; 2018–2028)

  • Orthopedic Implants
  • Cardiovascular Implants
  • Ocular Implants
  • Dental Implants
  • Others

Material Outlook (Revenue: USD Billion; 2018–2028)

  • Metals and Metal Alloys
  • Ceramics
  • Polymers
  • Biologics
  • Others

End-Use Outlook (Revenue: USD Billion; 2018–2028)

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Orthopedic Clinics
  • Academic and Research Institutes

Custom Requirements can be requested for this Report [Customization Available] @

Regional Outlook (Revenue, USD Billion; 2018–2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of MEA

Related Published Articles Published by Emergen Research:

Wearable Injectors Market

Laboratory Automation Systems Market

5G Chipset Market

Nanowire Battery Market

High Acuity Information Solutions Market

Waterproofing Systems Market

Construction Sealants Market

Hematologic Malignancies Testing Market

Immunotherapy Drugs Market

Spinal Fusion Devices Market

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Emergen Research Media Citations:

Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services

Press Release Available

Read Blog@

Back to news